Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel

BACKGROUND: Cervical cancer is a world-wide problem that requires transformative therapeutic strategies. We have previously developed patient-derived orthotopic xenograft (PDOX) nude-mouse models of this disease. In the present report, we demonstrate that the standard drug, cisplatinum (CDDP), is hi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Anticancer Res
Autores principales: MURAKAMI, TAKASHI, MURATA, TAKUYA, KAWAGUCHI, KEI, KIYUNA, TASUKU, IGARASHI, KENTARO, HWANG, HO KYOUNG, HIROSHIMA, YUKIHIKO, HOZUMI, CHIHIRO, KOMATSU, SHIN, KIKUCHI, TAKASHI, LWIN, THINZAR M., DELONG, JONATHAN C., MIYAKE, KENTARO, ZHANG, YONG, TANAKA, KUNIYA, BOUVET, MICHAEL, ENDO, ITARU, HOFFMAN, ROBERT M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5831332/
https://ncbi.nlm.nih.gov/pubmed/28011474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/anticanres.11289
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares